logo
Sign in

HBIO Stock Price, Chart, Stats & News

Harvard Bioscience, Inc.
Save
27.31M
Market cap
Current P/E
15.06x
Forward P/E

HBIO chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
53.01%
Operating margin
-0.73%
Pretax margin
-66.30%
Net margin
-65.51%
Effective tax rate
1.20%
ROA
-70.81%
ROE
-388.56%
D/E
3.22x
Interest coverage ratio
-0.13x

HBIO valuation

P/E
P/S
0.25x
P/B
1.57x
P/CF
3.34x
P/FCF
4.29x
P/OCF
3.34x
PEG
0.07x
EV multiple
-2.61x

About

Harvard Bioscience, Inc. (HBIO) is a global provider of cutting-edge technologies, products, and services crucial for fundamental scientific investigation, drug discovery, and preclinical testing. Serving both domestic and international markets, the company supplies an extensive range of cellular and molecular instruments. This includes precision fluid handling devices like syringe and peristaltic pumps, alongside a variety of tools and accessories for tissue and organ-based laboratory research, such as surgical instruments, infusion systems, and behavioral analysis setups.

Similar securities

Based on sector and market capitalization

Report issue